SynapCell

About:

SynapCell is a preclinical contract research organization, providing solutions for the therapeutic potential of CNS candidates in epilepsy.

Website: http://www.synapcell.fr/

Twitter/X: SynapC

Top Investors: Grenoble Angels, Rhone-Alpes Creation, Expansinvest, VIADUC 8

Description:

SynapCell is a French simplified joint-stock company founded in April 2005 and located at Grenoble, France. The mission of SynapCell is to bring added-value to CNS drug development by creating solutions for preclinical evaluation of CNS therapeutics and providing consulting, pre-designed and customized programs to experts in the biopharmaceutical industry.